Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Clinical usefulness of fused PET/CT compared with PET alone or CT alone in nasopharyngeal carcinoma patients.

Chen YK, Su CT, Ding HJ, Chi KH, Liang JA, Shen YY, Chen LK, Yeh CL, Liao AC, Kao CH.

Anticancer Res. 2006 Mar-Apr;26(2B):1471-7.

2.

Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET.

Antoch G, Saoudi N, Kuehl H, Dahmen G, Mueller SP, Beyer T, Bockisch A, Debatin JF, Freudenberg LS.

J Clin Oncol. 2004 Nov 1;22(21):4357-68.

PMID:
15514377
3.

Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?

Casneuf V, Delrue L, Kelles A, Van Damme N, Van Huysse J, Berrevoet F, De Vos M, Duyck P, Peeters M.

Acta Gastroenterol Belg. 2007 Oct-Dec;70(4):331-8.

PMID:
18330088
4.

Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography.

Chang JT, Chan SC, Yen TC, Liao CT, Lin CY, Lin KJ, Chen IH, Wang HM, Chang YC, Chen TM, Kang CJ, Ng SH.

Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):501-7.

PMID:
15890593
5.

Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT.

Comoretto M, Balestreri L, Borsatti E, Cimitan M, Franchin G, Lise M.

Radiology. 2008 Oct;249(1):203-11. doi: 10.1148/radiol.2491071753. Epub 2008 Aug 18.

PMID:
18710963
6.

[Clinical application of (18)F-FDG PET/CT to staging and treatment effectiveness monitoring of nasopharyngeal carcinoma].

Wang GH, Lau EW, Shakher R, Binns DS, Hogg A, Drummond E, Hicks RJ.

Ai Zheng. 2007 Jun;26(6):638-42. Chinese.

PMID:
17562272
7.

Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.

Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, Han J, Choi JY, Kwon OJ, Shim YM, Kim S.

Radiology. 2005 Sep;236(3):1011-9. Epub 2005 Jul 12.

PMID:
16014441
9.

PET/CT for staging and follow-up of pediatric nasopharyngeal carcinoma.

Cheuk DK, Sabin ND, Hossain M, Wozniak A, Naik M, Rodriguez-Galindo C, Krasin MJ, Shulkin BL.

Eur J Nucl Med Mol Imaging. 2012 Jul;39(7):1097-106. doi: 10.1007/s00259-012-2091-2. Epub 2012 Apr 25.

10.

Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.

Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.

Interact Cardiovasc Thorac Surg. 2010 Jun;10(6):1009-14. doi: 10.1510/icvts.2009.227538. Epub 2010 Mar 2.

PMID:
20197344
11.

The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis.

King AD, Ma BB, Yau YY, Zee B, Leung SF, Wong JK, Kam MK, Ahuja AT, Chan AT.

Br J Radiol. 2008 Apr;81(964):291-8. doi: 10.1259/bjr/73751469.

PMID:
18344274
12.

Preliminary study of 11C-choline PET/CT for T staging of locally advanced nasopharyngeal carcinoma: comparison with 18F-FDG PET/CT.

Wu HB, Wang QS, Wang MF, Zhen X, Zhou WL, Li HS.

J Nucl Med. 2011 Mar;52(3):341-6. doi: 10.2967/jnumed.110.081190. Epub 2011 Feb 14.

13.

FDG PET/CT in the management of nasopharyngeal carcinoma.

Mohandas A, Marcus C, Kang H, Truong MT, Subramaniam RM.

AJR Am J Roentgenol. 2014 Aug;203(2):W146-57. doi: 10.2214/AJR.13.12420. Review.

PMID:
25055290
14.

Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in patients with carcinoma of the nasopharynx: diagnostic accuracy and impact on clinical management.

Gordin A, Golz A, Daitzchman M, Keidar Z, Bar-Shalom R, Kuten A, Israel O.

Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):370-6. Epub 2007 Feb 26.

PMID:
17324532
15.

[Application of 18F-FDG PET/CT scan in following-up of nasopharyngeal carcinoma after radiotherapy].

Yu DF, Zuo CT, Dai JZ, Dong MJ, Zhao J, Lin XT, Guan YH.

Ai Zheng. 2004 Nov;23(11 Suppl):1538-41. Chinese.

PMID:
15566675
16.

[Combined FDG PET/CT imaging for restaging of colorectal cancer patients: impact of image fusion on staging accuracy].

Strunk H, Bucerius J, Jaeger U, Joe A, Flacke S, Reinhardt M, Hortling N, Palmedo H.

Rofo. 2005 Sep;177(9):1235-41. German.

PMID:
16123869
17.

MRI fused with prone FDG PET/CT improves the primary tumour staging of patients with breast cancer.

Garcia-Velloso MJ, Ribelles MJ, Rodriguez M, Fernandez-Montero A, Sancho L, Prieto E, Santisteban M, Rodriguez-Spiteri N, Idoate MA, Martinez-Regueira F, Elizalde A, Pina LJ.

Eur Radiol. 2017 Aug;27(8):3190-3198. doi: 10.1007/s00330-016-4685-8. Epub 2016 Dec 21.

PMID:
28004161
18.

Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma.

Tateishi U, Hosono A, Makimoto A, Nakamoto Y, Kaneta T, Fukuda H, Murakami K, Terauchi T, Suga T, Inoue T, Kim EE.

Ann Nucl Med. 2009 Feb;23(2):155-61. doi: 10.1007/s12149-008-0219-z. Epub 2009 Feb 19.

PMID:
19225939
19.

[Role of 18F-FDG PET/CT in diagnosis and staging of nasopharyngeal carcinoma].

Lin XP, Zhao C, Chen MY, Fan W, Zhang X, Zhi SF, Liang PY.

Ai Zheng. 2008 Sep;27(9):974-8. Chinese.

PMID:
18799039
20.

Supplemental Content

Support Center